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Coirradiation of the heart
enhances risk and severity of
radiation-induced lung
toxicity through an unknown
mechanism. We show that
irradiation of heart, lung, or
both independently induces
specific cardiac dysfunction
and pulmonary vascular
damage, mutually enhancing
each other. These results
show that treatment of
thoracic cancer with radia-
tion therapy requires optimi-
zation for both pulmonary
and cardiac function to
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Open access undIntroduction: The risk of early radiation-induced lung toxicity (RILT) limits the dose and effi-
cacy of radiation therapy of thoracic tumors. In addition to lung dose, coirradiation of the heart
is a known risk factor in the development RILT. The aim of this study was to identify the under-
lying physiology of the interaction between lung and heart in thoracic irradiation.
Methods and Materials: Rat hearts, lungs, or both were irradiated to 20 Gy using high-precision
proton beams. Cardiopulmonary performance was assessed using breathing rate measurements
and F18-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) scans biweekly and
left- and right-sided cardiac hemodynamic measurements and histopathology analysis at 8
weeks postirradiation.
Results: Two to 12 weeks after heart irradiation, a pronounced defect in the uptake of 18F-FDG
in the left ventricle (LV) was observed. At 8 weeks postirradiation, this coincided with LV peri-
vascular fibrosis, an increase in LV end-diastolic pressure, and pulmonary edema in the
shielded lungs. Lung irradiation alone not only increased pulmonary artery pressure and peri-
vascular edema but also induced an increased LV relaxation time. Combined irradiation of lung
and heart induced pronounced increases in LV end-diastolic pressure and relaxation time, in
addition to an increase in right ventricle end-diastolic pressure, indicative of biventricular dia-
stolic dysfunction. Moreover, enhanced pulmonary edema, inflammation and fibrosis were also
observed.
Conclusions: Both lung and heart irradiation cause cardiac and pulmonary toxicity via
different mechanisms. Thus, when combined, the loss of cardiopulmonary performance is
intensified further, explaining the deleterious effects of heart and lung coirradiation. OurDepartment of Radiation
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Ghobadi et al. International Journal of Radiation Oncology  Biology  Physicse640findings show for the first time the physiological mechanism underlying the development of
a multiorgan complication, RILT. Reduction of dose to either of these organs offers new oppor-
tunities to improve radiation therapy treatment of thoracic tumors, potentially facilitating
increased treatment doses and tumor control.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
For many thoracic tumors treated with radiation therapy, dose
escalation is expected to improve local control. However, the dose
that can be administered safely is limited by the risk of potentially
lethal radiation-induced lung toxicity (RILT). In a clinical situa-
tion, RILT manifests as respiratory distress and changes on thorax
radiograph and computed tomography (1).
Several treatment-related factors such as the radiation dose and
amount of irradiated lung tissue correlate with the risk of devel-
oping RILT (1). In addition to lung tissue, part of the heart is often
also irradiated (2). Although the heart is generally considered not
to be functionally affected early after irradiation, early radiation-
induced effects have been reported in animal (3) and clinical (4)
studies. Coirradiation of the heart was also shown to enhance
the risk of RILT both in animal studies (5, 6) and in patients with
non-small cell lung cancer (NSCLC) (2). Therefore, the contri-
bution of the heart as well as the lung in the development of early
RILT should be taken into account for treatment optimization.
Until now, however, the mechanism through which this interaction
takes place is not known.
Recently, it was shown in rats that lung irradiation induces
pulmonary hypertension and right ventricle hypertrophy in an
irradiated-volume-dependent manner (7). Pulmonary hypertension
can contribute to cardiac dysfunction (8). The possible contribu-
tion of radiation-induced pulmonary hypertension in cardiac
damage was suggested in the early 1990s in a canine model (9);
however, the underlying physiological changes remain unknown.
Taken together, these observations indicate that lung irradia-
tion can cause changes in the heart and that heart irradiation can
cause changes in the lung, leading collectively to physiological
changes in the cardiopulmonary system. Therefore, in this study
we investigated whether physiological changes caused by irradi-
ation of the lung, heart, or both can explain their interaction in the
development of radiation-induced cardiopulmonary dysfunction.
Methods and Materials
Animals
Adult male Wistar rats were used. The experiments were per-
formed in agreement with the Netherlands Experiments on
Animals Act (1977) and the European Convention for the
Protection of Vertebrate Animals Used for Experimental Purposes
(Strasbourg, 18.III.1986).
Irradiation technique
Rat hearts, lungs, or both were irradiated (single fraction) using
a high-precision proton beam (150 MeV) as described previously
(6). Briefly, high-energy protons were used, leading to uniform
dose distributions in the longitudinal direction (1%) with sharp
lateral field edges (20%-80% isodose distance: 1 mm). This steeppenumbra (0.9-1.1 mm) facilitates the separate irradiation of lung
and heart required for dissecting the individual contributions of
each on tissue damage and dysfunction. The rats were irradiated
under anesthesia (isoflurane) and suspended from their incisors.
The isodose curves of the irradiation portals (Supplementary Table
S1) are shown in Fig. 1.
Breathing rate assay
In preclinical studies, breathing rate (BR) is considered a surro-
gate measure for pulmonary function (7). The increase of the
postirradiation BR relative to the mean BR in weeks 0-2 after
irradiation was used as an indicator of early pulmonary dysfunc-
tion (7). Current data (nZ5/group) were combined with historical
data (5, 6).
Radiology
Electrocardiogram (ECG)-gated cardiac 18F-fluoridedeoxyglucose
positron emission tomography (18F-FDG-PET) scans were used to
investigate whether heart irradiation induces cardiac changes.
Reduction in 18F-FDG uptake of the left ventricle (LV) was scored
(Supplementary Table S2; nZ6/group) and reported as LV
18F-FDG uptake defect.
Hemodynamic measurements
LV or right ventricle (RV) hemodynamic measurements were
carried out to investigate cardiac physiological changes 8 weeks
after irradiation. For LV hemodynamic measurement (nZ5/
group), a pressure catheter was introduced via the carotid artery
and guided through the aorta into the LV to obtain LV end-
diastolic pressure (LVEDP) and Tau (LV relaxation constant).
RV pressure and pulmonary artery pressure (nZ4/group) were
recorded from RV hemodynamic measurement (7). Wet lungs
were weighed to check if they were edematous. The heart was
divided into atria, ventricles, and septum and weighed separately
to assess RV hypertrophy (7).
Morphological changes
Pulmonary edema, inflammation and fibrosis, as well as cardiac
perivascular fibrosis, were assessed in samples from the irradiated
and the shielded lung and heart (n4/group). Pulmonary edema
was assessed using hematoxylin and eosin staining and semi-
quantitative scoring of interstitial and perivascular edema. For
interstitial edema, scores from 0-3 were given reflecting the
severity of the damage to the interstitial tissue and the amount of
affected tissue with or without interstitial infiltrate. For perivascular
edema, scores from 0-2 were given to show the severity of the
edema around vessels. At least 5 large vessels (>100 mm) and 20
small vessels (<100 mm) with or without perivascular infiltrate
were scored. Using hematoxylin and eosin staining, pulmonary
Fig. 1. Isodose contours and anatomy. Colored areas indicate dose, and the solid and dashed contour indicate the outlines of the heart and
lung, respectively.
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number of inflammatory cells in the lung parenchyma. For fibrosis,
Masson trichrome staining was used. Pulmonary parenchymal
fibrosis was scored 0-3 based on the amount of deposited collagen.
Cardiac perivascular fibrosis was quantified by calculating the ratio
of the fibrosis area surrounding the vessel to the total vessel area
using an image analysis system (CZ KS400; Imaging Associates,
Bicester, United Kingdom). For this, at least 20 vessels were
examined, and, depending on the amount of vessels, the average
results per group were obtained from LVs of at least 4 rats.
Quantitative polymerase chain reaction
Total RNA was extracted from the phosphate buffered saline-
perfused rat LVs (nZ4/group), and cDNA was generated
subsequently according to the manufacturers’ protocols. Bio-Rad
IQTM SYBR Veenendaal, The Netherlands Green Supermix was
used to perform amplifications in a Bio-Rad IQ iCycler machine
as described by the manufacturer. The following primers
were used to amplify fibronectin: 50-agaccatacctgccgaatgtag
and gagagcttcttgtcctgtagag. The mRNA levels were normalized
using 36B4 (ribosomal) primers with the sequences 50-
gttgcctcagtgcctcactc and 50-gcagccgcaaatgcagatgg.
Statistical analysis
Differences between groups were tested by comparing the func-
tional and physiological parameters of the groups using 1-way
analysis of variance with Bonferroni post hoc analysis to correct
for multiple comparisons. For morphologic assessments,nonparametric Kruskal-Wallis test was performed. P values < .05
were considered statistically significant. To determine to what
extent the physiological changes could be explained by changes in
the morphology, Pearson’s product-moment correlation coefficient
was used. A correlation was considered significant if the
hypothesis of no correlation was rejected at P<.05.
More details can be found in the Supplementary Material.Results
Radiation induces early cardiac damage
To confirm the interaction between lungs and heart on radiation-
induced pulmonary dysfunction (5), we investigated the BR after
partial irradiation of the rat lung, with or without irradiation of the
heart. Coirradiation of the heart induced a pronounced BR
increase (Supplementary Fig. S1). This suggests that heart irra-
diation may induce early subclinical heart damage that manifests
only in combination with lung irradiation resulting in an aggra-
vated reduction in lung function (5). To determine whether heart
irradiation induces early cardiac damage, cardiac metabolism was
assessed by 18F-FDG-PET scans. Scans were taken biweekly for
12 weeks after irradiation of the heart and the adjacent lung tissue
(25% of the lung) with a dose below and above 18 Gy, the
threshold for lung-heart interaction (6). Indeed, a significant defect
in 18F-FDG uptake was observed in the LVs at both dose levels
(Fig. 2, P<.01 H þ 25% L, 16 Gy vs control and P<.001 H þ 25%
L, 25 Gy vs control).
Fig. 2. Cardiac metabolic changes after heart irradiation.
Scoring of reduced 18F-fluorodeoxyglucose positron emission
tomography (18F-FDG) uptake in irradiated hearts at diastolic
phase (week 2-12 postirradiation) (a) shows 18F-FDG uptake
defect in irradiated left ventricles to 16 and 25 Gy with more
pronounced effect in 25 Gy (b). The areas under the curves (week
2-12) were compared. ***P<.001, **P<.01, *P<.05 compared
with control. Data are presented as mean  SEM.
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myocardial damage
To investigate the origin of these metabolic changes, we investi-
gated the morphology of the LVs. Immunohistochemical staining
(Fig. 3a) and morphologic quantification (Fig. 3b, P<.01) showed
pronounced perivascular fibrosis in the irradiated LVs (20 Gy).
Moreover, in irradiated LVs, a relative increase in fibronectin
mRNA expression, a well-established profibrotic gene (10), was
observed (Fig. 3c, P<.05).
Aside from perivascular fibrosis, contraction bands (Fig. 3d,
yellow arrows) were observed in the myocardium of the irradiated
LVs located predominately in endocardium and epicardium.Heart irradiation induces left ventricle diastolic
dysfunction
Myocardial damage and perivascular fibrosis are known to be an
important pathophysiological processes contributing to diastolic
dysfunction by impairing cardiac relaxation (11, 12). Therefore,
we next investigated whether the observed histopathology and
metabolic changes translate into changes in cardiac function. To
this end, LV hemodynamics were assessed. Heart irradiation (20
Gy) induced a pronounced elevation of the LVEDP (Fig. 4a,
P<.05). Moreover, pericardial effusion was observed in 2 of 9
irradiated hearts. Next we determined to what extent radiation-
induced physiological changes can be explained by LV morpho-
logic changes, by correlating LV perivascular fibrosis with
LVEDP. The perfect correlation (Supplementary Fig. S2a) indi-
cated that LV diastolic dysfunction can be fully explained by
changes in cardiac vasculature.Heart irradiation enhances lung tissue damage
Because diastolic dysfunction is known to promote pulmonary
edema (13), it may be the mechanism through which heart irra-
diation induces pulmonary dysfunction. If so, this would lead to
pulmonary edema in shielded lung tissue. Morphologic analysis
showed significant pulmonary interstitial edema after heart irra-
diation (Fig. 5a, P<.001). Moreover, the wet weight of the lungs
was higher when the hearts were irradiated (Supplementary
Fig. S3). Also in 3 of 9 rats with irradiated hearts (20 Gy),
pleural effusion was observed. A strong correlation between
LVEDP and pulmonary interstitial edema (Supplementary
Fig. S2a) suggests that LV diastolic dysfunction induces
secondary lung damage. In addition to pulmonary edema,
morphological evaluation revealed more pulmonary parenchymal
inflammation and fibrosis (Fig 5b, P<.001 and P<.01 respec-
tively) when the heart was coirradiated.
Combined lung and heart irradiation: double
trouble
If irradiation of heart and lung both have a common consequence,
this would explain the observed interaction between them.
Importantly, irradiation of 50% of lung (20 Gy) has also been
shown to induce not only pulmonary edema (Fig. 5a,
Supplementary Fig. S3, P<.05) and inflammation (Fig. 5b, P<.05)
but also affect the heart due to increased pulmonary tension,
leading to RV systolic pressure overload and RV hypertrophy (7)
(Supplementary Fig. S4). Because all of these factors are known to
cause LV dysfunction (8), we investigated LV function after lung
irradiation. Indeed, significant elevation of tau (Fig. 4b, P<.05)
was observed. A strong correlation among pulmonary hyperten-
sion, perivascular edema, and tau (Supplementary Fig. S2b)
indicates that secondary cardiac damage can be explained by
radiation-induced lung damage.
We next investigated whether combining these effects by
simultaneous irradiation of both organs results in enhanced
response. To this end, cardiac performance was assessed after
heart þ 50% lung irradiation (20 Gy). Significant elevation of both
LVEDP (Fig. 4a, P<.01) and tau (Fig. 4b, P<.05), in addition to
perivascular fibrosis (Fig. 3b, P<.001) were observed in this
setting. Furthermore, enhanced wet lung weight increase
(Supplementary Fig. S2, P<.001), pulmonary interstitial edema
(Fig. 5a, P<.001), perivascular edema (Fig. 5a, P<.05), paren-
chymal inflammation (Fig. 5b, P<.001), fibrosis (Fig. 5b,
P<.001), and pleural effusion (5 of 9 rats) were observed in the
group that received combined lung and heart irradiation. In
addition to LV diastolic dysfunction, pulmonary edema may also
develop from RV diastolic dysfunction, because it may be induced
by pulmonary hypertension (Supplementary Fig. S4a and S4b).
Consistent with this, we also observed a pronounced increase in
RV diastolic pressure (Fig. 6, P<.001).
Discussion
Our results document the physiology of how cardiac and pulmo-
nary damage can mutually influence cardiopulmonary function.
We observed that heart irradiation directly affects cardiac vascu-
lature and myocardium and therefore increases end-diastolic
pressure, leading to LV diastolic dysfunction, which promotes
Fig. 3. Left ventricular perivascular fibrosis and myocardial damage in irradiated hearts, observed by immunohistochemical staining
(a, d), morphologic quantification of perivascular fibrosis (b), and relative fibronectin mRNA expression (c). Contraction bands (d, shown
by yellow arrows) were observed in the epicardium and endocardium of the irradiated hearts. Scale bars on panel a, d, and e represent
50 mm, 1 mm, and 100 mm, respectively. Masson trichrome staining was performed: red stain Z muscle fiber, blue stain Z collagen.
***P<.001, **P<.01, *P<.05 compared with control. Data are presented as mean  SEM.
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LV diastolic function through radiation-induced pulmonary
hypertension, pulmonary perivascular edema, and the resultant
effect on LV relaxation time. Combined lung and heart irradiation
enhances cardiac diastolic dysfunction via both mechanisms,
which may result in biventricle dysfunction, explaining the
observed aggravated cardiopulmonary dysfunction. We proposeFig. 4. Left ventricular hemodynamics after heart or lung irradiation, o
were observed in H þ 25% L and H þ 50% L groups (a), whereas elev
***P<.001, **P<.01, *P<.05 compared with control. Data are presentthat cardiac dysfunction, either originating directly from heart
irradiation or indirectly caused by lung irradiation, may be an
important factor causing or enhancing cardiopulmonary toxicity
after thoracic radiation therapy.
Consistent with our observations, changes in cardiac 18F-FDG
uptake were observed in patients with esophageal cancer 3-9
months postradiation therapy. Moreover, these changes correlatedr both. Significant increases in LVend-diastolic pressure (LVEDP)
ation of tau was observed in 50% L and H þ 50% L groups (b).
ed as mean  SEM.
Fig. 5. The morphology of the lung after heart or lung irradiation, or both. (a) Semiquantitative scoring of pulmonary interstitial (blue
arrows) and perivascular edema (black arrows). The numbers in the pictures show the given scores (interstitial edema: blue, perivascular
edema: black). The first, second, and third rows show representative examples of the lung tissue taken from nonirradiated controls, shielded
and irradiated parts, respectively. From left to right, columns show increasing levels of the tissue damage. Significant increase of global
pulmonary interstitial edema was observed when the heart was coirradiated with the lungs. Fifty percent lung irradiation with or without
coirradiation of the heart significantly increased pulmonary perivascular edema. (b) The first and second rows show semiquantitative
scoring of parenchymal inflammation in representative examples of the lung tissue taken from shielded and irradiated parts respectively
(hematoxylin and eosin staining). The third row shows semiquantitative scoring of parenchymal fibrosis in the lung tissue. The numbers on
the left upper corner of the pictures show the given scores (inflammation: black; fibrosis: blue). Coirradiation of the heart significantly
increased the number of inflammatory cells and the amount of deposited collagen in the lung tissue. Lung irradiation alone significantly
increases the number of inflammatory cells. Scale bar shows 100 mm. The purple bar shows increasing the level of tissue damage.
***P<.001, **P<.01, *P<.05 when compared with control. Data are presented as mean  SEM.
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marker of cardiac diastolic dysfunction in patients with acute
dyspnea (14).
In preclinical studies on RILT, BR increase is often considered
a surrogate measurement of radiation pneumonitis (1). Indeed,
these BR changes may reflect a reduced diffusion capacity due toparenchymal damage such as alveolitis. In addition, it may reflect
decreased ventilation efficiency as a consequence of reduced
perfusion, a symptom frequently observed in patients with
pulmonary hypertension and edema (7). Radiation-induced
pulmonary hypertension was shown to contribute to BR changes
not only in single irradiation dose preclinical studies (7, 9) but also
Fig. 6. Right ventricular (RV) hemodynamics after irradiation
of the heart and 50% of the lung. A dramatic elevation of RV
diastolic pressure (RVDP) was observed. ***P<.001 (H þ 50% L
vs Control), yyyP<.001 (H þ 50% L vs 50%). Data are presented
as mean  SEM.
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of cardiac diastolic dysfunction are also predominantly respiratory
in nature due to backward failure of the LV causing congestion of
the pulmonary vasculature and pulmonary edema (13). Consistent
with this, cardiac dysfunction was shown to play key role in the
development of BR increase in our study. Taken together, this
suggests that dyspnea may originate from physiological cardio-
pulmonary changes such as cardiac diastolic dysfunction and
pulmonary hypertension rather than parenchymal damage alone.
However, to substantiate our findings, studies with fractionated
dose in larger animal models or in patients should be performed.
Current practice in the optimization of the treatment of
NSCLC is mainly based on the dose distribution in the lungs and
the dose to spinal cord. The local control of the lung tumors could
be improved to w80%-90% by increasing the tumor dose by
w20% (16). At present, however, this dose escalation is not
possible in the majority of patients because of the associated risk
of RILT. Importantly, in our preclinical studies, differences in
tolerance dose between coirradiating and sparing of the heart were
typically in the same range (5, 6). Currently, conforming to the
dose constraints of the lung often results in an increase of dose to
the heart. Our present work shows that for a given lung dose,
increasing dose to the heart may in fact increase the risk of RILT,
thus hampering efforts for dose escalation. Therefore, adding dose
constraints for the heart in the treatment optimization for NSCLC
may allow dose escalation and consequently increase the local
control. Recently, preclinical and clinical studies have suggested
that models of RILT can be improved by accounting for the impact
of dose to the heart on the risk of complications (2, 6). However,
the approach to optimally distribute dose over the lung and heart is
still unclear. Because we now show that symptomatic RILT results
from physiological cardiopulmonary changes, dose-response
relationships of these changes such as LVEDP and pulmonary
artery pressure in patients incorporating both lung and heart dose-
volume variables are needed to build more accurate predictive
models.
In addition to dosimetric factors, pretreatment clinical factors
could be incorporated into the predictive models. Preexisting lung
diseases (17) and cardiac and pulmonary comorbidity (18) are
known to predict adverse effects of a treatment. More accurate
models will help to identify patients with a higher risk of RILT.
Notably, dose limits for the entire population is currently based on
these patients, accurately identifying them increases the toleranceof the residual population, thereby allowing tumor dose escalation.
The patients for whom tumor location and size prevents radiation
therapy with conventional modalities are suitable candidates for
dose escalation by more focalized radiation treatment modalities
such as particle radiation therapy (19). Here, the dose is more
confined to the target, and coirradiation of the heart and large
volumes of healthy lung tissue can be more effectively spared (19).
Symptoms of RILT were shown not to be limited to patients
with radiologic changes, nor were these changes exclusively
associated with symptomatic patients (20). Radiographically
occult factors such as vascular damage (7) and cardiac damage
(present results) may contribute to the development of RILT and
the associated symptoms. Therefore, in addition to diagnostic
tools of lung damage, (subclinical) cardiac damage should be
assessed for a better assessment of RILT.
Taken together, our findings show for the first time that
reducing the risk of the multiorgan complication RILT, requires
specific optimization of the treatment with respect to cardiac and
pulmonary dose. This may lead to the development of more
accurate prediction and more effective treatment of thoracic
cancers, thereby facilitating individualized dose escalation,
increased local control, and improved quality of life for patients
undergoing thoracic radiation therapy.References
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